Ignota Labs CSO Jordan Lane becomes an enterprise fellow at Clare Hall
Dr Jordan Lane, chief scientific officer at Ignota Labs, has been appointed industry and enterprise fellow of Clare Hall, Cambridge, for his extensive experience in the AI drug discovery space.
Earlier this year, Clare Hall announced the creation of the Industry and Enterprise Fellowship, a new category of senior membership for individuals with an established research or commercial track record, particularly in tech or biotech.
Dr Lane joins Dr Keith Dear, CEO and founder of Cassi, Dr Jiahao Huang, co-founder of Nuclera, Dr Loukik Arora, impact investment lead at Macmillan and Dr Quentin Harmer, CTO of Endomag, as the first people appointed to this new fellowship.
Despite being the smallest college by student number, Clare Hall is home to the largest visiting fellowship programme, with around 40 visiting senior academics in residence each year, as well as 24 research fellows, and senior members from varying professions beyond academia. The result is a diverse and close-knit international community with a focus on research.
Dr Lane leads innovation at Ignota Labs, leveraging his extensive background in drug discovery and AI to pioneer transformative treatments in global patient care. He is driven by “a profound commitment to revolutionising drug discovery, integrating artificial intelligence with bioscience to enhance drug safety and efficacy”.
Dr Lane said: “Cambridge’s innovation ecosystem thrives on cross-disciplinary collaboration and intellectually stimulating engagement with a diverse range of people.
“It is an honour for me to be appointed to this fellowship and I look forward to working with the extraordinary community at Clare Hall.”
Ignota Labs rescues promising but failing drugs, bringing new life to abandoned projects and new hope to patients. Since announcing a seed raise of £5.5million earlier this year, the biotech company has in-licensed multiple drugs, doubled the size of its team, and entered into a collaboration with global healthcare company Sanofi.
Clare Hall plans to expand the Industry and Enterprise Fellowship later in the year. Senior Tutor Holly Hedgeland at the College said: “We were delighted with the success of the initial call for the Industry and Enterprise Fellowship in May and a supplemental round of applications for the first cohort will be open in early September prior to our formal launch in Michaelmas.
“With expertise spanning the key technology areas of the Cambridge ecosystem we are excited to develop this new network linking academia and innovative industries, centred here at Clare Hall.”